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LETTER OF COMPLETION
March 27, 2007
Adam Gale, Executive Vice President of Operations
KLAS Enterprises, LLC
630 E. Technology Avenue
Orem, UT 84097

Dear Mr. Gale:
are pleased to submit to you our completed market research project. \'{Ie have thoroughly
sought to identify market trends and purchase behaviors withjn the medjcal imaging healthcare
industry as relating to cardjology imaging, women's health, and nuclear medjcine. We are confident
that our project and report will meet your expectations, and we hope that our findjngs and
recommendations wiJJ be useful to KLAS Enterprises, LLC in increasing revenue and profit.
\'{/e

The following report contillns the results of the research and includes the following:
•
•

Introduction to the Project
Research Objectives

•
•
•
•
•

Methodology
Findjngs
Analysis of the Findjngs
Conclusions
Recommendations

Thjs research study has been conducted as accurately as possible, with every effort taken to
reduce possible errors. Our team enjoyed tills experience and values it as a very important part
of our education. \'{Ie appreciate all the time and support you have given to tills project, and we
hope you continue to use BYU marketing students in the future.
Sincerely,
Hsieh-Banks Marketing

Trina Hsieh

Ginger Fillrbanks
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ENGAGEMENT LETTER

26 January, 2007
Adam Gale, Executive Vice President of Operations
KLAS Enterprises, LLC
630 E. Technology Avenue
Orem, UT 84097

Dear Mr. Gale:
As a group of undergraduate marketing students from the Marriott School of Management at
Brigham Young niversity (BYU Team), we look forward to working with you toward the
completion of the mammography market research project for I<lAS. The purpose of this letter is to
confirm our understanding of the project scope, approach, schedule, deliverables and fees.

Background
I<lAS Enterprises, LLC, founded in 1996, is the only research and analysis firm specializing in
monitoring and reporting the performance of HIT vendors and Professional Services Firms (PSFs).
Beginning in 2006, I<lAS also monitors the performance of medical equipment vendors. I<lAS'
mission is to imptove delivery of Healthcare Information Technology by honestly, accurately and
impartially measuring vendor performance for their provider partners.
I<lAS, in concert with thousands of healthcare executives, Chief Information Officers, directors,
managers and clinicians has created a dynamic database of information on the performance of HIT
vendors, PSFs and Medical Equipment vendors. The KLAS Database represents the opinions of
healthcare executives, managers and clinicians from over 4,500 hospitals and 2,500 clinics. The
Database contains ratings on 500+ products from 175+ vendors. The information is continually
refreshed with new performance evaluations and interviews daily.
Since adding medical equipment ratings last year, KLAS' 2007 strategy is to obtain more data and
ratings on various types of medical equipment for future report generation. I<lAS' major task is to
obtain market research data for medical equipment, specifically in the imaging area of
mammography.

Engagement Scope and Objectives
The BYU Team will complete a survey to determine consumer perception of mammography
equipment and upcoming trends/issues in women's health. In analyzing these findings, our team will
provide recommendations to assist in deciding whether I<lAS should create a report for digital
mammography.
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Approach, Tasks, and Schedule
Our suggested approach consists of the following four phases:

Pbase 1: Inforlllation Collection ana Discovery
The initial information collection will consist of one focus group to determjne what features
healthcare professionals desire in mammography equipment, what their current equipment lacks in
functionalj!:)/ how they chose to purchase from their current vendor, etc. and their interest in a
purchasable report containing comparable information amongst several vendors. Addjtionally, we
wilJ discuss their beliefs in upcomjng trends/issues in women's health. The work will be reviewed by
Jeff Boag of KLAS, at a meeting on February 13 at KLAS' offices in Orem, Utah.
Phase 2: Pro Forma Preparation ana Stlrvry
Using the information obtained in Phase 1, the BYU Team will execute its survey to a minimum of
50 healthcare professionals located nationwide.
Phase 3: AnalYsis
Based on tbe results of Phase 1 and 2, our team will use statistical tools to generate relevant
statistical data tbat will benefit KLAS in understandjng merucal equjpment in the mammography
market. The work will be combined into a complete report.

,
,

Pbase 4: Rep011 Delivery
The findillgs, analysis and final recommended plan of action will be subrnitted directly to KLAS.
The project will officially conclude with tills formal oral and written report to be presented by our
team to KLAS executives. The report wiJJ be made on or before 27 March 2007.
Deliverables
Two hard copies and one soft copy of the final written report will be delivered at the time of the
final PowerPoint presentation; all of these copies will become the proper!:)! of KLAS.

Roles of Engagement Team and Client
The BYU Team intends to deLver information that is reLable, representative, creruble and timely to
help KLAS achjeve its goals concerning medjcal eqwpment. The consulting team includes Ginger
Fairbanks and Trina Hsieh with Mark Thomas as the engagement coach and Dr. Michael Geurts,
professor of Business Management in the Marriott School of Management at BYU, as the advisor
for the project.

Owner of Intellectual Property
KLAS retains ownershjp rights to all intellectual proper!:) developed by the students as a resuJt of
their work and research findjngs. AJl students and faculty associated with the field sturues project
wilJ, at your request, sign a standard Assignment of Ownersrup and ondjsclosure Agreement. BYU
reserves the right to retain up to 10 copies of the final report for educational purposes. nless
notified otherwise by KLAS, one of these copies will be placed in the general reference section of
the Lee Library.
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Confidentiality

The BYU Team will make reasonable efforts to protect any confidential or proprietary information
that you provide to the Team, as long as you identify such information in writing at the time that
you provide it. Students and faculty wiJl freely discuss all other information associated with the
project as part of normal educational activities.
Publications

Faculty and students will have the right to publjsh and present information concerning the project.
If you notify us of intellectual property rights or confidential or proprietary information whjch
precludes complete djsclosure of the project, we will work with you to provide for both protection
of rights and appropriate publication. Of course, we will not rusclose your confidential information
in any such pubLcation.
Warranty Disclaimer

The project is an educational program designed to help students learn the practice of business
consulting. Students are not, however, considered employees or agents ofBYU. \'{/illle the team will
work in good faith to provide a quanty project, there is no promise of success. Accorrungly, B\'U, its
trustees, employees, agents, and students make no warrantees, express or impLed, as to the
conrution, accuracy, originanty, merchantabinty, or fitness for any particular purpose of any work
performed, advice given or intellectual property developed in the program and provide the work
performed on an as is basis. Further, KLAS agrees through its participation in the program that
BYU wilJ not be liable for incidental or consequential damage or of lost profits, even if B\'U is
advised of the possibility of such damages.
Indemnity

KLAS is to assume all risks and responsibinty with respect to its use of the work and research
provided to you under tms agreement, and agree to indemnify and hold harmless BYU, its trustees,
employees, agents, and students from any claim or liabinty, includjng reasonable attorneys fees,
arising from KLAS' use of the work or research provided to you.
Status Reporting

Every week, beginning the week of 19 January 2007, we will meet with KLAS executives to review
the achjevements to date and give the plan for the following week. If you requjre adrutional
information or have a particular comment or question, please contact us.
Fees

The fee for the team's work is $500, plus any orrunary expenses. Orrunary expenses include any
costs pre-approved by KLAS. Payment, payable to the Business Management Department, is due at
the time of the presentation.
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Team Professional Profile and Contacts
If you have any concerns or questions, please feel free to contact Trina Hsieh or tvlark Thomas at
the numbers or e-mails attached in the Professional Profile. The qualifications, names, e-mails and
telephone numbers of the team members are included in the Professional Profile.
look forward to working with you on thjs important endeavor. Please sign below, evidencing
your agreement to, and approval of the terms of this engagement letter. An original executed copy
of this letter should then be returned to Mark Thomas at the fo]]owing address:

\'{fe

Mark Thomas
Brigham, Young niversity
437 T lRB
Provo, Utah 84602
Sincerely,

Trina Hsieh
trina hsieh@byu.net
801.722.9989

Ginger Fairbanks
agfairbabv@gmilll.com
801.450.8770

Engagement Coach:

Mark Thomas
mark thomas@bvu.edu
801.422.8928

Professor:

Dr. {ike Geurts
michael geurts@byu.edu
801.422.2398

Accepted by:
Signature:

Date:

_

Authorized Representative of KLAS
Print lame and Title:

_
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Team Professional Profile and Contacts

If you have any concerns or questions, please feel free to contact Trina Hsieh or Mark Thomas at
the numbers or e-mails attached in the Professional ProfIle. The qualifications, names, e-mails and
telephone numbers of the team members are included in the Professional Profile.
W/e look forward ro working with you on tills important endeavor. Please sign below, evidencing
your agreement to, and approval of the terms of this engagement letter. An original executed copy
of thjs letter should then be returned to Mark Thomas at the following address:
Mark Thomas
Brigham, Young ruversity
437 TNRB
Provo, Utah 84602
Sincerely,

Trina Hsieh
trina hsieh@bvu.net
801.722.9989

Ginger Fairbanks
agfillrbabv@gmail.com
801.450.8770

Engagement Coach:

Mark Thomas
mark thomas@byu.edu
801.422.8928

Professor:

Dr. Mjke Geurts
rruchael geurts@byu.edu
801.422.2398

Accepted by:
Signature:

Date:

_

Authorized Representative of KLAS
Print

ame and Title:

_
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EXECUTIVE SUMMARY

KLAS is an independent healthcare researcher headquartered in Orem, Utah, that provides accurate,
honest, and unbiased ratings and information on medical equipment, professional services, and
healthcare software.
Our objectives in the project were to gather research data and perform corresponding analysis that
will allow us to make recommendations to KLAS for the company's future mecUcal equipment
reports, and to help KLAS gain a better understanding of how the Deficit Reduction Act is affecting
imaging centers nationwide.
We fulfilled these objectives through a four-part process which included:
1. Conducting an in-depth interview with Lee Gallagher, the Senior Adminjstrator at Central
Utah Clinic to better understand some of the key issues concerning merucal imaging.
2. Developing a survey regarcUng future jmaging modality investments and the effects of the
DRA on existing merucal imaging centers. We obtained a sample size of 16 healthcare
professionals from imaging centers across the nation
3. Analyzing the data to quantitatively identify sign.ificant trends in imaging equjpment
purchasing plans for medical imaging centers.
4. Interpreting the data to make recommendations for KLAS.
After objectively looking at the data, our key recommendations are as foUows:
• DR Mammography Unit is the Top Priority Purchase in Women's Health
• Purchase Plans are Being Influenced by the DRA
• Nuclear Medicine is not a Top Purchasing Priority
• 64-Slice CT Scanner is the Top Priority Purchase in CarcUology Imaging
• There is a strong association between CarcUology Imaging and Women's Health
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PURPOSES
The purpose of this research project is to determine upcoming trends/issues around specific areas
of medical imaging in addition to gairung an understanding of what impact the DRA is having on
imaging centers nationwide. From this research, we wiD answer the following questions:
1. \X/hat specific investments are being made around cardiology imaging for the next two years?
2. \X!hat specific investments are being made around women's health for the next two years?
3. \'\/hat specific investments are being made around nuclear medicine for the next two years?
4. How is the DRA affecting imaging centers?
5. What is the magnitude of the DRA's effect?
6. Are vendor performance evaluation reports of interest to imaging centers?
Answering these questions will help KLAS to gain an overall understanding of the medical imaging
field and allow our BYU team to make recommendations as to what the company should focus on
in the near future.

PROCEDURES
Hsieh-Banks Marketing followed several steps during this project to retrieve and assure accurate
information. Below are the procedures that we followed:

p,.elil1linary Steps
• Meet with JeffBoag, director of medical imaging research at KLAS, to understand the client needs
and define the target market
• Create objectives that our project seeks to realize

Pre-St/17Jf!)I Steps
• Conduct an in-depth interview with a person who fits the profile of our target market to better
understand their concerns, needs and wants. This person was Lee Gallagher, Senior Administrator
at Central tah Clinic
• Create a survey to uncover plans, needs, and wants from several consumers from our
target audience; asking measurable questions with statistical significance, in order to make
appropriate recommendations
• Determine when, where, and how to conduct the survey, whether it be via email, phone, fax,
traditional mail, or other means

SNrvry Steps
• Administer the survey, making sure we get enough responses to merit useful, valid, and valuable
information
• Input the results of the survey

]Jost-StII7Jf!)I Ana!ysis
• Analyze the results of the surveys to evaluate the responses to each question and to find
other associations and correlations that may be of interest

!(LAS®
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• Form conclusions that provide answers to our pre-project guestions
• Use the in-depth interview, survey response data, and final conclusions to form recommendations
concerning main factors that are influencing current trends in the medjcal imaging eguipment
purchasing field, and illgh- or low-intent to purchase
• Present our findings along with our recommendations to Adam Gale, Jared Petersen, Jeff Boag, as
well as other executives and research directors/managers from KLAS and our Marketing Research
class in a verbal presentation and a written document

DELIMITATIONS AND SCOPE
The scope of this report was limited to standalone imaging centers as set by KLAS. The survey was
admirustered to these facilities across the nation via telephone, email and fax.
W/e chose to give admiruster surveys in thjs manner to try and increase our response rate. The
Limited time frame that this semester allowed us could not guarantee that we would acilleve our
response goal. However, we djd find that malcing phone calls with a follow fax of our survey gave
the illghest success and response rate.

LIMITATIONS
Non-response Error. This was not a sigruficant problem for us because all respondents who took
our survey completed every guestion. However, there were a few instances where we administered
the survey to a potential respondent who declined to complete the survey. Tills resulted in a small
amount of non-response error for our research.
Frame Error. The frame error present in our research does have the effect of preventing a random
sample. Our potential survey respondents came from a national imaging center wrectory published
in 2006, owned by KLAS. Using tills list of facilities for our survey data has resulted in slight frame

error.

I<LAS.
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BACKGROUND
KLAS Enterprises, LLC, estabLshed in 1997, is headquartered in Orem, Utah with independent
researchers working throughout the country. KIAS is independently owned and operated, and the
name "KLAS" comes from the first initials of the founder's names: Kent Gale, Leonard Black,
Adam Gale and Scott Holbrook.
KLAS helps healthcare providers make informed technology decisions by offering accurate, honest,
impartial vendor performance information. They gather and provide tl,is data by independently
monitoring vendor performance through the active participation of thousands of healthcare
organizations. KLAS uses a stringent methodology to ensure aU data and ratings are accurate, honest
and impartial. Research results are offered to health care providers through:

•
•
•

A free directory of vendor and product information
Free online access to vendor ratings for participating providers
In-depth published reports, discounted for participating providers

\X!hen healthcare purchasers are in the market to purchase new medical software, a new modaLty,
or improved technology services of some kind, they find themselves being in charge of making a
hundreds of thousands, or even millions of dollars investment. KLAS' understands the importance
of making an honestly informed decision for the greatest benefit of the hospital, staff, and patients.
As such, KLAS mission is to improve the de]jvery of healthcare technology by independently
measuring and reporting on vendor performance.

!(LAS®
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OBJECTIVES
Primary Objective: To gather research data and perform correspondjng analysis that will allow us
to make recommendations to KLAS for the company's future merucal equipment reports.
Secondary Objective: To help K1
imao-inocenters nationwide.
b
b

S gain a better understanrung of how the DRA is affecting

METHODOLOGY
Our original objective for this research project was to see if there is going to be a great transition for
most imaging centers across the nation to djgital mammography. However, after our in-depth
interview with Lee Gallagher, the Seruor Admirustrator at Central Utah Cliruc, we discovered that
DR mammography is still fighting for its place, because of the newer technology and the cost of
purchasing and implementing such a system. As such, we decided to broaden the scope of our
project to Cardjology Imaging, Women's Health, and Nuclear Merucine.
Surveys were administered through several djfferent meruums to a specific target auruence, inclurung
healthcare professionals such as Chief Information Officers, business managers, department
managers, physicians, or technicians. First, we decided to admjruster aU surveys by phone,
considering the anticipated djfficulty to get a hold of our target customer. To do so, we obtained an
information list of nationwide imaging centers with their cliruc name and phone number. Then, we
reserved interview rooms and phones in the Career Center on the Brigham Young Uruversity
campus in the Tanner Buildjng to admiruster these surveys. \'{/e spent approximately 8 h urs a week
for three weeks collecting our information.
We djd, however, run into several problems. Although we had anticipated having a rufficult time
getting completed surveys, our responses proved more difficult to obtilln than previously thought.
The first hurdle to jump was getting past the contact's 'gatekeeper', that person being an assistant,
office personnel, or receptiorust who is trained to screen calls. After multiple unsuccessful phone
calls, we decided to change our approach. We would offer the gatekeeper an alternate way to
complete the survey without granting us direct access to our target customer, through either:
a) sending the gatekeeper or the target an emillJ with the survey hnk provided, to be completed
witrun a specified time frame
b) sending the gatekeeper, or the target a fax to be completed witilln a specified time frame
We started out with a sample size goal of 50 responses; two from each U.S. state to provide for
equal geographic distribution. Although we rud achjeve a.greater success rate by offering these two
alternative ways to complete surveys, we only came up WIth a sample size of 16 even after more than
26+ hours of various survey collection procedures.
We have a sample size of 16 people purely due to the inherent rufficulties with contacting our
particular market segment (we were working with healthcare professionals whose time is extremely
valuable and scarce).
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We recorded our data in Qualtrics and Excel, and used SPSS statistical software

to

analyze the data.

All categorical data was analyzed using cross tabulation and chj-square statistics. The interval data

was analyzed using correlation and regression. \\/hen both interval and categorical data were
analyzed together, cross-tabulation and ern-square statistics were used.
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QUESTIONNAIRE RESULTS
Question 1 - What types of services does your faciJjty offer? (select all that apply)
Count
0
9
7

Response
Cardiology
Raillology
Both

Cardiology
0%

Both
44%
Radiology
56%

Question one shows that the majority of respondents offer only radjology services but a fajr number
do offer both carillology and raillology services.
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Question 2 - Are you making any investments around cardiology imaging for 2008 and 2009?

~
No

2

Question two shows that the majority of respondents are planning on making investments around
cardiology imaging during the next two years.
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Question 3a - Are you making any investments around cardjology imaging for 2008 and 2009? If
yes, which modaljty wilJ you purchase first?
Upgrade/New Installation
Upgrade
Upgrade
Upgrade
New Installation
New Installation

Type
64-slice CT
64-slice CT
64-slice CT
128-slice CT
dSPECT cardjac scanner
Type

Installation Date
2008
2008
2007
2008
2007

Upgrade/New Installation

''''

64-slleo CT

New
Installation
40%

20%

12S-slice CT

Upgrade
60%

dSPECT cardiac

20%

scanner

00/.

10%

20%

300/0

400/.

50%

600/.

70%

SOo/.

90%

100%

000/.

90%
80%

70%
60 %

60%
50%
400/.
400/.

30%
20%
10%
0%
2007

2008

arc: Tonds mighr nor cqual 100 pcrccnr duc ro rounding.

Question three shows that the majority of respondents indicate their first priority is to purchase a
64-slice CT scanner. It is interesting to observe that most of the purchases mentioned are upgrades
and most respondents stated that their installation date will take place in 2008.
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Question 3b - Are you makjng any investments around cardjology imaging for 2008 and 2009? If
yes, which modality will you purchase second?
Only two respondents inwcated that they were makjng a second purchase within carwology imaging.
Wie have summarized this data in a table due to the few responses.
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Question 4 - Are you making any investments around women's health for 2008 and 2009?

~
8

o

No
44%

Yes
56%

Question four shows that the s]jght majority of respondents are making purchases around women's
health withjn the next two years.
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Question Sa - Are you making any investments around women's health for 2008 and 2009? If yes,
which modality will you purchase first?
Upgrade/New Installation
Upgrade
Upgrade
Upgrade
New Installation
New Installation
New Installation
Upgrade
Upgrade
New Installation

Type
64-slice CT
DR Mammography
DR Mammography
DR Mammography
DR Mammography
DR Mammography
DR Mammographv
MRI
Ultrasound
Type

Installation Date
Unknown
2009
Unknown
2007
2007
Unknown
2008
2008

Upgrade/New Installation

67%

OR Mammography

New
Installation
44%

11%

54-slice CT

MRI

11%

Ultrasound

11%

0%

10%

20%

30%

40%

50%

60%

70%

80%

900/..

Upgrade
56%

100%

Installation Date
00%

900/.
80%
70%
60%
50%
40%
30%

25%

25%

2007

2008

20%
10%
0%

Unknown

2009

ate: Totals might not equal 100 percent due to rounding.

Question five shows that the majority of respondents indicate their first priority is ro purchase a DR
Mammography unit. It is interesting to observe that most of the purchases mentioned are upgrades
and most respondents stated that their installation date is unknown.
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Question 6 - Are you making any investments around nuclear medicine for 2008 and 2009?

~
No

11

No
79%

Question six shows that the majority of respondents are not making purchases around nuclear
medicine witl-un the next two years.
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Market Intelligence Leaders •

Question 7 - Are you making any investments around nuclear for 2008 and 2009? If yes, which
modaEty will you purchase first?
Upgrade/New Installation
New Installation
New Installation
New Installation

Type
dSPECT
PETjCT
SPECTjCT

Installation Date
2007
2009
2008

33"

SPECT/CT

0%

100/0

20%

300/0

40%

500/.

60%

700/.

80%

90%

100".

Installation Date
100%

90%
800/.
70%

60%
50%
400/.

33"

33"

33"

2007

2008

2009

30%
20%

10%
0%

Note: Totals might not equal 100 percent due to rounding.

It is interesting to observe that questions seven responses are evenly distributed. The three
respondents who indicated they were making investments around nuclear medicine each gave a
dj fferent response of what type of unit and the installation date. All respondents djd indicate that
these purchases will be new installations.
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Question 8 - How has the DRA influenced your future modality purchase plans?

Lower
reimbursements/revenues

38%

No effect

13%

No purchases

0%

10%

20%

ate: Totals might not equal 100 percent due

to

30%

40%

50%

60%

70%

80%

90%

100%

rounding.

Based upon the responses gathered, we were able to categorize them into three areas: lower
reimbursements/revenues, no effect, and no purchases. The majority of respondents indicated that
they have felt the DRA's influence as lower reimbursements and revenues. The following are the full
answers given by survey respondents.
Responses
We are being sold withjn the next three to four months, so we aren't making any additional
purchases.
ot really. We're still a new facility only about two years old and we're doubling the size of our
hospital to meet the demand.
We have not felt the full effects yet.
It has affected our family of exams. For example, for each MRl exam we only get half
reimbursement for the second exam, one-quarter reimbursement for the third exam, etc..
Bottom-line reimbursement; we need to increase volumes without decreasing quality, wruch is giving
us cause to seriously look as to whether to invest in new eqwpment to improve throughput.
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Two milljon revenue reduction
More thought on upgrarung 16-slice to 64-slice CT and loST MRl to 3T MRl due to money.

r j\
Yes, less reimbursement means less return on investment, which means when equipment needs to
be replaced; it may not make economic sense.
Holding off on major purchases/upgrades untiJ revenues stabilize, inclurung software upgrades.
r one
Lower reimbursements
o reimbursements, lower revenues
ahead with planned purchases.
o , we are movinob
We are a hospital. It has not influenced.
Carefully studying return on investments before purchasing.

I<LAS.
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Question 9 - In what other ways have you been affected by the DRA?
Only a few respondents indjcated that there were other DRA effects felt besides affecting
purchasing plans. The following responses are given in full text but not categorized or charted.

Responses

NA
Minor degree

NA
Concerned other payers will follow suit.

NA
NA
\'\!e have put off business expansion and growth in underserved areas.
None
In order ro make it now, hospitals and imaging centers have to be aggressive and need sigruficant
study volumes. New exams and new technology are illscouraged by the government now because of
the DRA; they are not interested in provirung that new technology to us. Reimbursements are the
same on aU technologies, e.g. 1.ST and 3T MRI so there is no incentive to bring in new technology
even thought patient care is better.
\'\Ie are trying to cut costs where possible.
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Question 10 - For research purposes, how interested would you be in an independent report
containing side-by-side vendor performance evaluations for each modality?
Very Interes ted
Interested
Undecided
ninterested
Very Uninterested

Very Interested

Interested

7%

33%

Undecided

Uninterested

40%

Very Uninterested

0%
10%
20%
30%
40%
Note: Totals might not equal "100 percent due to rounding.

50%

60%

70%

80%

90%

100%

Question 10 shows that most respondents are either uninterested or interested in vendor
performance reports, similar to those that KLAS offers. Many of the "uninterested" responses were
due to the fact that imaging centers do their own research or automatically choose amongst familiar
vendors that they have worked with.
Many of those respondents who answered that they would be interested in such report expressed
frustration of uying to move past vendors' sales and marketing. Imaging centers care more about the
functionality and fit of a piece of equipment versus the heavy selling of vendor representatives.
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FINDINGS AND ANALYSIS
Strong Correlation Findings
To further understand jf there are any trends in medjcal imaging requjred us to run correlations
between the interval data sets on our survey. Thjs analysis would help us to know if there were any
strong associations between our data sets. As we went through the correlations, we found seven
correlations proved to be significant. Because of non-response error, we were unable to calculate
regressions for each of tllese seven correlations. The following tables and explanations are in regard
to the only four regressions that we could run. See Appendi.x E for a list of the other findjngs that
could prove valuable to KLAS if further explored.
1. Services Offered vs. Women's Health Purchase Plans
RegresJioll S'lalislics
Multiple R
0.629941
R Square
0.396825
0.353741
Adjusted R Square
Standard Error
0.415133
16

Observations
A lOVA

1
14
15

S'S'
1.587302
2.412698
4

MS
1.587302
0.172336

9.210526

Sigllificallce F
0.008913

Coe tciell/J
-1.04762
0.634921

Sialldard Envr
0.520397
0.209207

I Slat
-2.01311
3.034885

P-va/lle
0.063744
0.008913

Lower 95%
-2.16376
0.186215

df
Regression
Residual
Total

F

Upper
lntercept
Services Offered

95%

0.068522
1.083626

LOUieI' 95.0%
-2.16376
0.186215

U er 95.0%
0.068522
1.083626

The preceillng table contains the regression statistics for Services Offered versus Women's Health
Purchase Plans. One can see that the correlation value, R, is 0.63 rounded and the coefficient of
determination, R-squared is 0.397 rounded. From this, we observe mat there is a moderately strong,
positive correlation between mese two variables. Adilltionally, we understand mat 39.7 percent of
the variation in Women's Health Purchase Plans can be explallled by me Services Offered by me
imaging center.
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2.

Cardiology Imaging Purchase Plans vs. Women's Health Purchase Plans

Regressiol/ Sialislics

Multiple R
R Square
Adjusted R Square
Standard Error

0.645497
0.416667
0.3
0.316228

Observations

7

AN OVA
S.\·

rlf

Regression
Residual
Total

1I1S

F

0.357143
0.1

3.571429

Siglltfical/ce F
0.117387

1
5
6

0.357143
0.5

Coe tciel/ls
0.5

Slclllriarrl E JT(n'
0.223607

I Sial
2.236068

P-va/lle
0.075587

LOIJ/er95%
-0.0748

0.5

0.264575

1.889822

0.117387

-0.18011

0.857143
Upper

Intercept
Cardjology
Imaging Purchase
Plans

1.0748

LOIIJer95.0%
-0.0748

U er 95.0%
1.0748

1.180112

-0.18011

1.180112

95%

The preceding table contains the regression statistics for Cardiology Imaging Purchase Plans versus
Women's Health Purchase Plans. One can see that the correlation value, R, is 0.65 rounded and the
coefficient of determination, R-squared is 0.417 rounded. From this, we observe that there is a
moderately strong, positive correlation between these two variables. Additionally, we understand
that 41.7 percent of the variation in Women's Health Purchase Plans can be explained by the
Cardiology Imaging Purchase Plans of the imaging center.
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3.

Cardiology Imaging Purchase Plans vs. Purchase Intention

Regressioll SlaliJ/icJ
0.034922
Multiple R
0.00122
R Square
-0.19854
Adjusted R Square
1.529706
Standard Error
7

Observations
ANOVA

SS

df

1I1S

F

0.014286
2.34

0.006105

I SIal

P-vaille

Sigllificallce F

Regression
Residual

1
5

0.014286
11.7

Total

6

11.71429

Coe tcim/J
2.5

Sialldard El1vr
1.081665

2.311251

0.0688

-0.28051

5.280509

-0.28051

U er95.0%
5.280509

0.1

1.279844

0.078135

0.940752

-3.18994

3.389943

-3.18994

3.389943

0.940752

Upper
Intercept
Cardiolol:,')'
Imaging Purchase
Plans

LOIIJer95%

95%

LOJ//er 95.0%

The preceding table contains the regression statistics for Cardiology Imaging Purchase Plans versus
Purchase Intention. One can see that the correlation value, R, is 0.03 rounded and the coefficient of
determination, R-squared is 0.001 rounded. From this, we observe that there is a very weak, positive
correlation between these two variables. Additionally, we understand that only 0.1 percent of the
variation in Purchase Intention can be explained by the Cardjology Imaging Purchase Plans of the
imaging center.

I<LAS®

Market Intelligence Leaders •

4.

Cardjology Imaging Installation Time vs. Women's Health Installation Time

Re.?/uJiol/ SlaliJ/irJ
0.218218
Multiple R
0.047619
R Square
-0.26984
Adjusted R Square
0.942809
Standard Error

5

Observations
f\NOVA

SS

rlf

MS
0.133333
0.888889

Regression
Residual

1
3

Total

4

0.133333
2.666667
2.8

Coe trim/J
0.666667

Slal/rlanl Error
1.440165

0.46291

0.333333

0.860663

0.387298

F

Sigl/ificCil/ce F
0.15

0.724377

Upper
Intercept
Cardiology
Imaging
Installation Time

t SIal

P-va/ue
0.674941

LOJlJer95%
-3.91658

95%
5.249913

Lolller95.0%
-3.91658

U er 95.0%
5.249913

0.724377

-2.40568

3.072347

-2.40568

3.072347

The preceillng table contillns the regression statistics for Cardiology Imaging Installation Time
versus \'V'omen's Health Installation Time. One can see that the correlation value, R, is 0.22 rounded
and the coefficient of determination, R-squared is 0.048 rounded. From tills, we observe that there is
a weak, positive correlation between these 1:\:1/0 variables. Addjtionally, we understand that only 4.8
percent of the variation in Women's Health Installation Time can be explained by the Cardiology
Imaging Installation Time of the imaging center.
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5. \X/omen's Health Purchase Plans vs. DRA Effects
Regressiol/ Statistics
i\fultiple R
R Square
Adjusted R Square
Standard Error

0.566947
0.321429
0.272959
0.582482

Observations

16

ANOVr\

SS

r/(

\IS
2.25
0.339286

Regression
Residual

14

Total

15

2.25
4.75
7

Coe zrieJlts
2.125

Stal/r/arr/ Envr
0.205939

t Stat
10.31861

-0.75

0.291241

-2.57519

1

F
6.631579

Sigl/ifical/ce F
0.022014

Upper
Intercept
\X/omen's Health
Purchase Plans

P-lJa/m
6.33E-08

LOJJler95%
1.683306

2.566694

LOJlJer95.0%
1.683306

U er 95.0%
2.566694

0.022014

-1.37465

-0.12535

-1.37465

-0.12535

95%

The preceding table contains the regression statistics for \Xlomen's Health Purchase Plans versus
DRA Effects. One can see that the correlation value, R, is 0.57 rounded and the coefficient of
determination, R-sguared is 0.321 rounded. From this, we observe that there is a moderate positive
correlation between these two variables. Additionally, we understand that 32.1 percent of the
variation in DRA Effects responses can be explained by the Women's Health Purchase Plans of the
imaging center.
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Weak Correlations Findings

We calculated the following correlation studies and we djd not find them to be sigruficant:
1. Services Offered vs. Cardiology Imaging Purchase Plans
2.

Services Offered vs.Cardjology Imaging Equipment - Upgrade/New Installation

3. Services Offered vs. Cardiology Imaging Installation Time
4.

Services Offered vs. Cardiology Imaging Equipment - Upgrade/New Installation (2)

5. Services Offered vs. Cardiology Imaging InstaIJation Time (2)
6. Services Offered vs. Women's Health Equipment - Upgrade/New Installation
7. Services Offered vs. \'{!omen's Health Installation Time
8. Services Offered vs. Nuclear Medicine Purchase Plans
9. Services Offered vs. Nuclear Medicine Installation Time
10. Services Offered vs. DRA Effects
11. Services Offered vs. Purchase Intention

12. Cardiology Imaging Purchase Plans vs. Cardiology Imaging Equipment - Upgrade/New
Installation
13. Cardiology Imaging Purchase Plans vs. Cardiology Imaging Installation Time
14. Cardiology Imaging Purchase Plans vs. Cardiology Imaging Equipment - Upgrade/New
Installation (2)
15. Cardiology Imaging Purchase Plans vs. Cardiology Imaging Installation Time (2)
16. Cardjology Imaging Purchase Plans vs. Women's Health Equipment - Upgrade/New
Installation
17. Cardiology Imaging Purchase Plans vs. Women's Health Installation Time
18. Cardiology Imaging Purchase Plans vs. Nuclear Medicine Purchase Plans
19. Cardiology Imaging Purchase Plans vs. Nuclear Medicine Equipment - Upgrade/New
Installation
20. Cardiology Imaging Purchase Plans vs. Nuclear Medicine Installation Time
21. Cardiology Imaging Purchase Plans vs. DRA Effects
22. Cardiology Imaging Equipment - Upgrade/New Installation vs. Cardiology Imaging
Installation Time
23. Cardiology Imaging Equipment - Upgrade/New Installation vs. Cardiology Imaging
Equipment - Upgrade/New Installation (2)
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24. Cardiology Imaging Equipment -

pgrade/ I ew Installation vs. Cardiology Imaging

Installation Time (2)
25. Cardiology Imaging Equipment - Upgrade/New Installation vs. Women's Health Purchase
Plans
26. Cardiology Imaging Equipment - Upgrade/New Installation vs. Women's Health
Equipment - Upgrade/ ew Installation
27. Cardiology Imaging Equipment -

pgrade/ ew Installation vs. Women's Health

Installation Time
28. Cardiology Imaging Equipment - Upgrade/New Installation vs. Nuclear Medicine Purchase
Plans
29. Cardiology Imaging Equipment - Upgrade/New Installation vs. Nuclear Medicine
Equipment - Upgrade/I ew Installation
30. Cardiology Imaging Equipment -

pgrade/ ew Installation vs. Juclear Medicine

Installation Time
31. Cardiology Imaging Equipment - Upgrade/New Installation vs. DRA Effects
32. Cardiology Imaging Equipment - Upgrade/New Installation vs. Purchase Intention
33. Cardiology Imaging Installation Time vs. Cardiology Imaging Equipment - Upgrade/ ew
Installation (2)
34. Cardiology Imaging Installation Time vs. Cardiology Imaging Installation Time (2)
35. Cardiology Imaging Installation Time vs. Women's Health Purchase Plans
36. Cardiology Imaging Installation Time vs. Women's Health Equipment - Upgrade/I ew
Installation
37. Cardiology Imaging Installation Time vs. Nuclear Medicine Purchase Plans
38. Cardiology Imaging Installation Time vs.

uclear Medicine Equipment - Upgrade/ ew

Installation
39. Cardiology Imaging Installation Time vs.

uclear Medicine Installation Time

40. Cardiology Imaging Installation Time vs. DRA Effects
41. Cardiology Imaging Installation Time vs. Purchase Intention
42. Cardiology Imaging Equipment - Upgrade/ ew Installation (2) vs. Cardiology Imaging
Installation Time (2)
43. Cardiology Imaging Equipment -

pgrade/ ew Installation (2) vs. Women's Health

Purchase Plans
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44. Cardjology Imaging Equipment - Upgrade/Ne'w Installation (2)

VS.

Women's Health

VS.

Women's Health

Equipment - Upgrade/New Installation
45. Carcliology Imaging Equipment - Upgrade/New Installation (2)
Installation Time
46. Cardjology Imaging Equipment - Upgrade/New InstaIJation (2) vs. Nuclear Meclicine
Purchase Plans
47. Cardjology Imaging Equipment - Upgrade/New Installation (2) vs. Nuclear Medjcine
Equipment - Upgrade/New Installation
48. Cardiology Imaging Equipment - Upgrade/New Installation (2) vs. Nuclear Medicine
Installation Time
49. Cardjology Imaging Equipment - Upgrade/New InstaIJation (2) vs. DRA Effects
50. Cardiology Imaging Equipment - Upgrade/New Installation (2) vs. Purchase Intention
51. Cardjology Imaging Installation Time (2) vs. Women's Health Purchase Plans
52. Cardiology Imaging InstaIJation Time (2) vs. Women's Health Equipment - Upgrade/New
Installation
53. Cardjology Imaging Installation Time (2) vs. Women's Health Installation Time
54. Carcliology Imaging Installation Time (2) vs. Nuclear Medicine Purchase Plans
55. Cardjology Imaging Installation Time (2) vs. Nuclear Medicine Equipment - Upgrade/New
Installation
56. Carcliology Imaging Installation Time (2) vs. Nuclear Medicine Installation Time
57. Cardiology Imaging Installation Time (2) vs. DRA Effects
58. Cardiology Imaging Installation Time (2) vs. Purchase Intention
59. Women's Health Purchase Plans vs. Women's Health Equipment - Upgrade/New
Installation
60. Women's Health Purchase Plans vs. Women's Health Installation Time
61. Women's Health Purchase Plans vs. Nuclear Medicine Purchase Plans
62. Women's Health Purchase Plans vs. Nuclear Medicine Installation Time
63. \X/omen's Health Purchase Plans vs. Purchase Intention
64. Women's Health Equipment - Upgrade/New Installation vs. Women's Health Installation
Time
65. Women's Health Equipment - Upgrade/New Installation vs. Nuclear Medicine Purchase
Plans
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66. \X/omen's Health Equipment -

pgrade/ lew Installation vs.

uclear Medjcine Equipment

f

pgrade/ ew Installation
67. Women's Health Equipment - Upgrade/New Installation vs. Nuclear Medjcine Installation
Time
68. Women's Health Equipment -

pgrade/I ew Installation vs. DRA Effects

69. Women's Health Equipment - Upgrade/ ew Installation vs. Purchase Intention
70. \X/omen's Health Installation Time vs.
71. Women's Health Installation Time vs.

f

uclear Medicine Purchase Plans
uclear Medjcine Equjpment - Upgrade/New

Installation
72. \X!omen's Health InstalJation Time vs. Nuclear Medicine Installation Time
73. Women's Health Installation Time vs. DRA Effects
74. Women's Health Installation Time vs. Purchase Intention
75.

uclear Medjcine Purchase Plans vs.

uclear iferucine Equjpment -

pgrade/ ew

Installation
76. Nuclear Medjcine Purchase Plans vs. Nuclear Merucine Installation Time
77. Nuclear Medicine Purchase Plans vs. DRA Effects
78.

f

uclear Merucine Purchase Plans vs. Purchase Intention

79.

f

uclear Medicine Equipment - Upgrade/ ew Installation vs.

f

uclear Merucine Installation

Time
80. Nuclear Merucine Equipment 81.

pgrade/ ew Installation vs. DRA Effects

uclear Merucine Equipment - Upgrade/ ew Installation vs. Purchase Intention

82. Nuclear Merucine Installation Time vs. DRA Effects
83. Nuclear Medjcine Installation Time vs. Purchase Intention
84. DRA Effects vs. Purchase Intention
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Significant Association Findings
\Xie performed many cross tabulations with different categorical elements and only included ones

that were relevant to KLAS with a 90 percent confidence level.

Finding 1- 9808 percent confident
Varia Me 1: Sen/ices 0Jlered
ValiaMe 2: I/;/'oll/en's rIealll) PlIrcbase Plans
Finding 2 - 95.4 percent confident
Vanoable 1: Services OJlered
VCI/iable 2: Nile/ear Medicine EqlliplJlenl- Upgrade/ l\ ell; Installatioll
Finding 3 - 9407 percent confident
ValiaMe 1: Cardiology iII/aging Purcbase PlallS
Vanoable 2: 10/?"oll/eI1'S Healtl) PlIrcbase PIaIlS
Finding 4 - 9208 percent confident
VCI1iable 1: Cardiolo!)! III/aging P1Ircbase PlclI7s
Variable 2: Purcbase Intention
Finding 5 - 91.8 percent confident
Valiab/e 1: Cardiology Il1Iaging Installatioll Tillie
VaJiable 2: IVol1leJ7 's Healtb Installation Til7/e
Finding 6 - 95.4 percent confident
Variable 1: l/?"ol1len's Healtb PlIrcbase Plcl!1s
Valiable 2: !'.JlIe/ear lv/edicine Equipment - Upgrade/

ell; Installation

Finding 7 - 92.4 percent confident
Vanoclble 1: WOl1len's Healtb Purcbase Plalls
Variable 2: DRA EJlects
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CONCLUSIONS AND
RECOMMENDATIONS
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CONCLUSIONS
DR Mammography Unit is the Top Priority Purchase in Women's Health
67 of the 56 percent who are making investments around women's health indicated that their top
priority is purchasing a DR mammography unit for 2008-2009.
purchase Plans are Being Influenced by the DRA
50 percent of respondents indicated that their future modality purchase plans have been influenced
due to lower reimbursements/revenues caused by the DRA. However, 38 percent felt no effects.
Those not feeung affects of the DRA are more ukely to purchase, and those experiencing lower
reimbursements are not as ukely to purchase equipment.
Nuclear Medicine is not a Top Purchasing Priority
79 percent of respondents indicated that they are not making purchases around nuclear medicine for
2008-2009.
64-Slice CT Scanner is the Top Priority Purchase in Cardiology Imaging
60 of the 71 percent who are making investments around cardiology imaging indicated that their top
priority is purchasing a 64-suce CT scanner for 2008-2009.
There is a strong association between Cardiology Imaging and Women's Health
"I've been in healthcare for 25 years and I have seen women's health change dramatically. In the
past when women had a heart attack, it was a surprise. So, up until recently, say the last ten years,
[the doctors] thought heart disease was a men's killer, but actually heart disease is the number one
killer of women, because it's not caught early."
-Lee Gallagher, Senior Admjrustrator, Central Utah Cunic
•
•
•

There is a weak, positive correlation (.22) between cardjology imaging installation time and
women's health installation time
There is a moderate, positive correlation (.63) between services offered [cardiology,
radjology, or both] and women's health purchase plans
There is a moderately strong, positive correlation (.65) between cardiology imagjng purchase
plans and women's health purchase plans
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RECOMMENDATIONS
Publish a DR Mammography Study
Considering that 67 percent of respondents indicated that a DR mammography unit is their top
priority under women's health purchases, we recommend that KLAS publishes a DR mammography
study

Conduct More Research in Cardiology Imaging/Women's Health
Cardjology imao-ing appears to be an increasingly signjficant trend in women's health; KLAS should
conduct more research in this area to determjne what reports could be generated
postpone Nuclear Medicine Studies
Due to the low demand discovered in our findjngs, KLAS should not invest around nuclear
medicine equjpment studies at this time
Further Investigate DRA Effects
Because our findings show that the DRA is influencing imaging centers' purchase plans, KLAS
should further investigate thjs issue
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APPENDIX A: IN-DEPTH INTERVIEW TRANSCRIPTION
with Lee Gallagher, Senior Administrator, Central Utah Clinic

Central Utah Clinic,pc
Yoor Ht.oJth. Your Choke....

Jeff: Now I'm just curious Lee, what role do you play there at Central Utah?
Lee: Actually, I'm the senior admjnistrator there. Central Utah Clinic is the largest multi-specialty
clinic in the state of Utah. We have over 90 physicians and we will have 100 by end of this year.
Jeff: What is causing so many physicians to come on board? Is it through recruiting?
Lee: Some through recruiting because of the growth in area neerung more specialists, Part of it is
because doctors' groups that are small want to join a larger group just because it is easier - we have
more negotiating power with supplies and insurance companies because we are large, So we have
internal merucine, cardiology, neurology, ENT, orthoperucs, imaging center, lab, we have pretty
much everything,
Jeff: \Vell, I'm serving as the mentor here and I'm actually with a research company. So, we focus on
healthcare IT and equipment research, IS what we do. And so, a lot of times people see the swt and
they think "vendor, vendor, vendor" but no, no, not a vendor. In fact, most vendors probably want
to shoot me, because our research sometimes isn't always favorable about their products. So, I was
very interested when they contacted me and said, 'We're interested in doing a market research
project on healthcare," S~ they said, "What trends, are you seein~ in health~are?" I said, "you know,
here's some things that I m seell1g around women s health: there s a lot of ll1vestment and a lot of
people innovating around women's health, So we're seeing djfferent groups evaluating how they
move forward with women's health investment, specialty practices, etc. So, I appreciate you being
here.
Lee: I've seen a lot of changes, I've been in healthcare for 25 years so, as a matter of fact, I don't
know anything else, But, I have seen a tremendous amount of changes, specifically, in specializations
and technology, So, give me an idea, when you say you are studying market research, specifically are
you looking for tren?s and how is this information going to be used so that I best give you the
information? Focus In on what you really want,
Trina: \Vell, the general objective of our research project is we want to see if there is going to be a
great transition for most.imaging centers ~cr~ss the nation to ~gital mammography from CR or
uJtraso und or CT - that IS our general obJective, but we are CUriOUS to see general trends 111
women's' health, maybe in nuclear merucine or carruac sturues, So, we have a specific objective but
at the same time we want to have a broad understanrung. I'm not sure if that answered your
questions,
Lee: I think it did. Digital mammography is still fighting for its place. There are a lot of studies that
state now that the rugital mammography is not only as good as the trarutional mammography, but
for younger women who have denser breasts it is even better, How I explain rugital mammography
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versuS digital mammography is that trarutional mammography is more like our 35 mm cameras
where we took the picture, and then we got it processed and then we had our pictures. So,
traditional mammography, you take the pictures and then you process them and cllen you hang them
up to look at them. If you need to look at one specific area you get out your magrlifying glass and
you look at that. Ok, so that is the trarutional mammography; that's the way that a lot of people do it
right now.
Jeff: So, it's an analog mammography; we are not talkjng about CR. We're talkjng about a straight,

analog x-ray.
Lee: Right, just an x-ray. The digital mammography is like your rugital camera now - you can put
them on the computer and you can enlarg the pictures, you can see them right away, you can
enlarge the pictures so that you can zoom in on those areas of interest instead of getting out your
magl,jfying glass. Another advantage to rugital mammography is that the programs have what they
caJJ CAD, which is computer aided diagnostics. So, the computer will actually highbght for the
raruologist the areas that the computer thinks is, "Hey, look at this." Like I said, the radiologist can
zoom in, wiJJ have a computer to help - so much more accuracy than the analog mammography.
Jeff: Just out of my curiosity here, are you seeing CAD bundled with a CR or DR when it's being

sold?
Lee: Yes.
Jeff: Is the equipment vendor con,jng and bundling the CAD solution at the same time? Is it coming
from a single source, how have you seen It?

Lee: It comes from the vendor - the original vendor.
Jeff: Have you seen anybody come in that doesn't necessarily own the CAD software side, they just

have the modality?
Lee: I have not seen that.
Jeff: That's what I'm trying to get my head around.

Lee: In me healthcare field, I'm not seeing ir.
Jeff: Ok, like wirJ: 64-slice C.T, Toshiba partners with Vital Images. So Toshiba just focuses on the
equipment and VItal comes In WIth the workstation alone, but they sell it together. So you're buying
a Toshiba 64-slice CT but you're getting a Vitrea workstation.

Lee: Ok, weJJ men I take that back. Because when you have a CT, there are vendors, like
TeraRecon, mat will sell me software for me packages, but they sell it at me same time.
Jeff: So it's coming in from the equipment vendor, on the same purchase order.

Lee: Yes.
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Jeff: So, you're not saying, "Oh, I have to go deal with TeraRecon now." You might deal with them
with support on the back end, but not on the initial sale.
Lee: Right, as a matter of fact, there are some software packages that are sold separately. Say, if you
have a CT unit, then you may start out doing your "bread and butters", maybe even your carcLacs if
you're getting the 64-sJjce scanner, even the cardiacs. But, what if we want to do an add on for, Jjke,
virtual colonoscopies, then you can eIther go back to GE, or whoever you got the product from, or
you can go to a place Jjke TeraRecon or Aculmage, they wilJ sell the software for those programs
separately.
Jeff: So, Hologic just bought R2 for the CAD. They djdn't have the software expertise so they just
acquired R2.

Lee: And GE does that all the time. GE just bought out a big company that we use too, IDX. They
just bought out IDX.
Jeff: Now it's GE Centricity. So, instead of Imagecast, or whatever I'm used to hearing, it's
Centiricty.

Lee: And we happen to use Centricity and we have a full PACS system.
Jeff: Do you run a RIS along with your PACS?
Lee: Yes, that's the IDX. We use the IDX - so everythjng is cLgital. We have electronic mecLcal
records, we have electronic billing; all of our images are actually online that will be available for
referring physicians.
Jeff: I was going to ask you about telemecLcine. When I was irutially talking about that jump from 90
to 100, my immecLate thought was, "How are your investments assisting you in that expansion? I
mean, is that part of the reason physicians are not ready ro sign up for that? I mean DRA, and a
bunch of other tllings, are scary to you right now.
Lee: That's right, especially with imaging centers.
Jeff: So, let's just jump in and share the RIS with a bunch of other folks.
Lee: Exactly. Because witll the DRA, it is precLcted, but you never know how thillgs will really turn
out, it is precLcted tllat a lot of the small imaging centers will have to either join groups or go out of
business.

Jeff: I taJked to a group in Juniper, Florida two weeks ago. They just bought their 64-sJjce in the
Iwddle of last year; 85 percent of thelt population base are MecLcare/MecLcaid paid so the entire
ROI plan that tlley put together, I mean I don't care how much throughput, we're only doing 10
scans a day, I mean it wasn't a huge volume yet. But, they said where mey're really getting killed,
immecLately, was on meir nuclear stucLes. I mean, their nuke studies are $200.
Lee: We have nuclear studies mere; I'm not over tllat division of it, but we do have it. My
racLologists read the nuclear stucLes; the nuclear stucLes are done by the carcLology department. But,

I<LAS.

Market Intelligence Leaders

my radiologists help out with that, things like the bone scans and non-cardiacs. " e have seven
radiologists in our group.
Jeff: And how many cardiologists?
Lee: I'm thinking between 8-12, something like that.
Jeff: So are the radiologists doing the over read, I mean, how are they doing referrals on their, what,
CTAs?
Lee: For the CTAs, the radjologists and cardiologists work together.
Jeff: Radiologists do the irutial read, throw it over the fence and then say, "Hey, look at thjs."
Lee: WeD, at the hospitals they just kind of split it up 1 thjnk.
Trina: I'm kind of interested; I'm not very farnibar with Central tah. What kind of
mammographies do you offer? Have you gone djgital at Central Utah?
Lee: Right now, we have the only djgital mammography urut in

tah County. IHC is getting a urut.

Jeff: Which vendor did you go with for the DR?
Lee: We go through GE; we're practically a GE shop. We have a Siemens ultrasound, but pretty
much GE.
Ginger: So, what made you go with GE, instead of another vendor, for your digital?
Lee: Actually, no, for the digital we're with Hologic. For the mammography unit, we're with
Hologic. But our MRls and CTs, are GE, our PACS system, our flumo urut. ~!e have fluoroscopies.
I have 11,000 square feet of my imaging center, we're bujlding another imaging center in American
Fork.
Jeff: What type of MR do you have? I mean is it a 1.5T?
Lee: We have 1.5, two of them.
Jeff: The multi-channel?
Lee: Yes. We do cardiacs on them. We are the only facility in Utah County that does carruac MRls.
Jeff: How are they physicians like it?
Lee: They love it.
Jeff: Do you have a 64-slice CT?
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Lee: We are getting one. The Timpanogos Hospital, right now, is the only one in Utah County that
has one. IHC is getting theirs soon.

Jeff: Have you selected one yet?
Lee: We're getting the GE. I've done a lot of the research on the 64-slice.

Jeff: We talked to about 300 facilities that have implemented Hitachi, well not as much Hitachj, but
GE, Phibps, Siemens and Toshiba, some Hitachi
Lee: For the 64-sljce, I didn't even talk to any of the other vendors. 64-sbce, in the indusuy, GE is
the best, as far as support services, compatibibty with other modalities, etc. We're very happy with
GE.

Ginger: So, since you did mention that you were primarily a GE shop, you said that for your digital
mammography you go with Hologic. Why did you choose that over GE?
Lee: I was not here during that purchase; I've only been in Utah for a year and a half.

Ginger: So, did you work with some other digital mammography in Atlanta?
Lee: 0, this is the first digital mammography unit that I've had. I've worked with analog
mammography in Atlanta, Florida and Alabama.

Ginger: As far as patient comfort goes, I know that a lot of women don't go in because it's not
comfortabl . I mean, my mom says that she never wants to go in again, because she had the
traditional. So, do you think, with the digital, it's a lot more comfortable for the patients?
Lee: It's still being squashed, so it stiJJ hurts. But, since it's so fast, the compression...when I say
squashed it just means compression ... as you can see, I'm used to talk.ing to a lot of lay people.
That's because I do a lot of talks on women's health especially in Atlanta. I did talks on women's
cardiac issues, and mammography, and just general wellness. But, for the patient to come in to the
djgital mammography versus the tradjtional mammography, the only thjng that they will see
djfferent is that it doesn't take as long, so the compression is not as long, and the results are
immediate, and at least at our facibt:y, that means that if you need a biopsy, then you can a lot of
times, if you need an ultrasound, many times you can get it that same day. That's because the
ultrasound unit is right across the hall from the mammography unit. So as far as imaging centers, if
they have that type of patient care, then I think that they will do fine.

Ginger: And you mentioned that thjs is your first digital mammography unit to work with. Do you
thjnk that the other places you've worked, why don't they have digital yet?
Lee: The expense. It's very, very expensive and the carriers are not paying for the CAD yet. Some of
them are not.

Trina: You did say that you mentioned the DRA, obviously, is having a huge effect on that as well.
Lee: Right.
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Jeff: So, I'm curious about that last comment on the carriers not paying for CAD. How is that
broken out, when you submit to the payer, you know Medicaid or Medjcare, is there a separate line
item or charge for the CAD realling.
Lee: Yes.
Jeff: Interesting.
Lee: We're not officially a GE shop, but Hitachi came in, we're getting a Hitachj MRl.
Jeff: How many slice?
Lee: It's a 0.8 MR.
Jeff: 0.8? Oh, MR, sorry. Whjch MR? I can't remember the product name for it.
Lee: It's an Ares. But, when Hitachj, we were meeting with them for the construction, the Hitachj
construction guy asked us had we worked with GE since we're getting a GE CT scanner. The
Hitachi salesperson said, "It's a GE shop."
Trina: So, it sounds like Central Utah is expandjng qwte a bit?

Lee: Oh yes, we have over 600 employees.
Jeff: It's a large special ty practice when you get close to over 100 physicians.
Trina: 1 know you had mentioned that there were a few pieces of equjpment that Central Utah is
plamung on purchasing, are there any others?

Lee: 0, we've done our limit; we don't plan on purchasing any more eqwpment in the future. I
mean, there's really not much else to buy. Central Utah Clinic is a pioneer in the community. If it's
out there, they're usually one of the first ones to do it. The only thing we don't have right now is
PET.

Jeff: PET CT or just a straight PET?
Lee: PET CT, we wouldn't do a straight PET. As a matter of fact, Hjtachj sells a straight PET.
Jeff; I don't know for how much longer.
Lee: Right, I don't see it. Are you Oef£) a member of the AHRA?
Jeff: We are as a corporation.
Lee: One thjng that you will find about Utah vendors, that I have found out, because I have lived in
a lot of different states, is some of us go with GE and things like that for service. Because, Hjtachj
has to come out from Denver; GE has reps right here.

I<LAS.

Market Intelligence Leaders

Jeff: You know what's so amazing? 1 can't tell you how many times I've talked to, like, Siemens, and
I'm looking at thjs data while I'm talking to someone down in Florida, well actually the whole
Southeast, and they were killing Siemens on support. Because they couldn't get parts, they couldn't
o-et reps, that is a hugely populated part of the Uruted States. Usually 1 hear that in Alabama or
bLouisiana, or Utah, you I,now k
id
.n
ofthe" me too " states.
Lee: I contacted Siemens out of Melbourne, PA. And, about getting information, probably about
the CT 64. They illd not contact me back. 1 called and left a message and sent them an email. A
couple months go by, and then, that was it.
Jeff: So, GE has the local reps, the local support here in Salt Lake?
Lee: Yes.
Jeff: Did you see that announcement about GE's CR?
Lee: Yes we did.
Jeff: Ouch! Yeah, 1 sent a notice out to aU the researchers, talk to somebody who has a CR.
Lee: We have their CR but we don't have any problems with it.
Jeff: Are they doing a recall on it? What are they doing?
Lee: Only on a part, not the whole CR.
Jeff: 1 just read the press release; 1 haven't talked to anybody.
Lee: And from what 1 understand, 1 could be wrong, was GE just bought out BC not that long ago,
and now they've sold it again.
Jeff: 1 illdn't know that.
Lee: Like I said, I could be wrong. I can't imagine that could even be correct. What do you know
about the EBT?
Jeff: The EBT? I know notrung.
Lee: It's not going to be around that much longer, I'm sure. Wruch is a shame because, man, it was
a great macrune. GE bought it, but then th.ey buried it. But the only trung it does, and thjs is
somerrung more about technology, 1S that Jt only does hearts really well. Cardiac calcium scoring; it
does those really well.
Trina: I know you mentioned on the phone trus morrung that you were interested in opening up a
women's health facility, is that correct?
Lee: Eventually.
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Trina: I'm assuming that means that there isn't a facility in the Utah County area.
Lee:

1

at that I know of.

Jeff: St. Marks is the only dedjcated women's faciljty that 1 k.now of, that's up in Salt Lake.
Lee: That's the only one that 1 know of. I'm not getting a lot of encouragement, because they don't
feel that the demand is out there. But to me, you create the demand. Like I said, I've been in
healthcare for 25 years and 1 have seen women's health change dramatically. Not that long ago,
when women had a heart attack, it was a surprise. Because with heart rusease, it comes on you, it
graduaIJy builds up. And sometimes your first heart attack with women is not always noticeable. And
then the doctors, at least 10 the past, now recently, they have started to change thjs. But in the past,
they thought heart rusease was a men's killer, but actuaUy heart rusease is the number one killer of
women, because it's not caught early. People, doctors trunk that women are just going through
menopause, "oh you have too much stress in your life." So, for women, jt was not a recogruzed
problem. A lot of times when women had their heart attacks, their major heart attacks, it was over
with. It kjIJed them instantly. So, up untIl recently, say the last ten years, you saw women's health:
you got your mammogram, you got your GYN exam, you got your pap smear and you got your
annual physical... but the men, got a chest x-ray, they got a stress test, they got their ESA, they had a
whole program for men but the women had just this jjttle stuff. "\X!ell you don't get sick, you last
forever, what more do you want?" That was their philosophy. So, with the new technology, there are
things bke ... the AcuScan in Salt Lake, where they do the heart scans. And the 64-slice scanners can
do those as well. And I recommend, that's what I was saying, the demand isn't out there, but you
have to let people know what's available to women. Marketing is not just creating awareness on
somethjng that maybe you don't have a demand, you create the demand.
Jeff: WeIJ, what's neat about Utah, is I've noticed that, it seems bke the news here does a really good
job of coverage because of ties in to the Huntsman Cancer Institute; it's like they always have
somethjng, you know, cuttlng edge where they showed that new, what was it, it was one of their
nuclear sturues where they had a whole separate facility for their reactor, you know for their brain
cancer. It's ljke a tllree-story builrung that houses trus nuclear. Trus trung's going to zap your head
with it; I mean it's pretty amazing. I can't remember what it was, it was bke a $100 million dolJar
piece of equjpment; there's only a few of them in the Uruted States. You know, I thjnk that it's just
so important to get the word out, espec1ally because Utah has 1tS own demograprucs and challenges.
Lee: Utah is on the cusp; good old boys, and then the advancement, they're right there ... they're
getting out of their good old boys but you still find them.
Jeff: Well, your ide~ on having your marketing people going to church groups, you know just doing
an educational semmar. How great 1S that?
Trina:

ow, what do you wnk mjght be the time frame on trus women's facility?

Lee: It's not even in the planrung stages; it's still up in my head.
Jeff: It's just an idea.
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Lee: Now, it may not even happen since we do have a lot of things for women. \X!e have a GYN
and we have mammography and we have all of that, so it would just be pulling together an official
program.
Jeff: Your MR unit, is it capable of doing MR mammo? Do you have the coils to do that?
Lee: Yes, we do. \Vie do have breast on our MR. And our radjologists have gone to school and
training for that.
Ginger: Now, is there anythjng in your DR unit that you don't like or somethjng that you would like
to see that it lacks?
Jeff: On the Hologic unit?
Ginger: Yes.
Jeff: So your DR mammo. Any features or functions that you'd uke to see them develop down the
road?
Lee: To be honest, the techs love it. So, they haven't really complained. And I hear their whining; I
do hear them complain. But, so far they like it. \X!e also do teleramology, through the Centricity
program.
Jeff: Do you know how the CAD will work with that? I mean, so, doctors sit in their remote office,
I was trying to figure out.
Lee: You can't. You couldn't do the 64-slice, the cardjac, you can't do that. You couldn't transfer it
to a workstation to do post processing.
Jeff: \'{/ill you bund out a new, separate reading room with all these new equjpment purchases?
Lee: No, we just use the same reamng room. \'{Ie have three ramology reamng workstations, one for
our cardiologists.
Jeff: Are you doing TeraRecon? No? Everything GE?
Ginger: So, would you say that the only reason imaging centers are not going to DR mammography
is just because of the price?
Lee: Yes.
Ginger: So, every other reason they want it?
Lee: Our facility in Alabama, we would have loved to have a DR, but it's just too much. It's very,
very expeoslve.
Trina: About how much?
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Lee: Probably $300,000 to $500,000; because the ultrasound was $200 and somethjng thousand with
all the probes. And aga.in, 1 wasn't there for the purchase.
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APPENDIX B: TRENDS IN MEDICAL IMAGING SURVEY

*This survey will be used for educational purposes only, all responses are strictly confidential*
1.

2.

What types of services does your facility offer? (select alJ that apply)
a. Cardiology
b. Radiology
Are you making any investments around cardjology imaging for 2008 and 2009?
a. Yes
_

b.
3.

No

Jf so, which mo d aJI" tv will vou pu rc lase:

Priority

Type

Model

New Install/Upgrade

Installation Date

First
Second

4.

Are you making any investments around women's health for 2008 and 2009?
a. Yes
b. 1 a
If so, which modaJjty WI·U you purc h ase:

5.
Priority

Type

Model

Installation Date

New Install/Upgrade

First
Second
6.

Are you makjng any investments around nuclear medjcine for 2008 and 2009?
a. Yes

b. No
If so, whjch modauty will you purchase:
Priority
Type
Model
7.

New Install/Upgrade

Installation Date

First
Second
8.

How has the DRA influenced your future modality purchase plans?

9.

In what other ways have you been affected by the DRA?

10. For research purposes, how interested wouJd you be in an independent report contairung side-by-side
vendor performance evaJuations for each modaLty?
Very Interested
Interested
Undecided
Uoj nterested
Very Unjnterested
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ApPENDIX C: SIGNIFICANT CROSS TABULATIONS
This appendix contains associations that are significant. These associations were determined to
be significant by creating a cross tabulation. The chi-square statistic is below 0.1 for all
associations in this section. This means that we are 90% sure that these associations are
indicative of the parent population. Included graphics are (I) the cross tabulation for each set of
variables and (2) the chi-square statistic chart. We suggest that KLAS further investigate these
associations. It may be that with further research these associations can be shown to have
relevant, strong correlations.

Finding 1 - 98.8 percent confident
Variable I: Services Offered
Variable 2: Women's Health Purchase Plans
We are 98.8 percent confident that these findings are representative of the population.
Services Offered * Women's Health Purchase Plans Cross Tabulation
Women's Health
Purchase Plans
No
Services Offered

Total

Yes

Radiology

7

2

9

Both

1

6

7

8

8

16

Total

Chi-Square Tests

Value
Pearson Chi-Square
Continuity
Correction(a)
Likelihood Ratio

I

df

Asymp. Sig.
(2-sided)

6.349(b)

1

.012

4.063

1

.044

6.904

1

.009

Fisher's Exact Test

Exact Sig.
(2-sidedl

.041

Linear-by-Linear
Association

5.952

N of Valid Cases

16

1

Exact Sig.
(1-sidedl

.020

.015

I<LAS®

Market Intelligence Leaders •

Finding 2 - 95.4 percent confident
Variable I: Services Offered
Variable 2: Nuclear Medicine Equipment - Upgrade/New Instal/at ion
We are 95.4 percent confident that the association between these two variables is significant.
Services Offered * Nuclear Medicine - Upgrade/New Installation Cross Tabulation

Nuclear Medicine
Eaui( ment
Upqrade
Services Offered

Total

New Install

Radiology

1

0

1

Both

0

3

3

1

3

4

Total

Chi-Square Tests

Pearson Chi-Square
Continuity
Correction(a)
Likelihood Ratio

Asymp. Sig.
(2-sided)

df

Value
4.000(b)

1

.046

.444

1

.505

4.499

1

.034

Exact Sig.
(2-sided)

.250

Fisher's Exact Test
Linear-by-Linear
Association

3.000

N of Valid Cases

4

1

Exact Sig.
(1-sided)

.250

.083
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Finding 3 - 91.2 percent confident
Variable I: Cardiology Imaging Purchase Plans
Variable 2: Women's Health Purchase Plans
We are 91.2 percent confident that these findings are representative of the population.
Cardiology Imaging Purchase Plans· Women's Health Purchase Plans Cross Tabulation

Women's Health
Purchase Plans
No
Cardiology Imaging
Purchase Plans

No
Yes

Total

Total

Yes
1

1

0

5

5

1

6

7

2

Chi-Square Tests

Pearson Chi-Square
Continuity
Correction(a)
Likelihood Ratio

I

df

Value

Asymp. Sig.
(2-sided)

2.917(b)

1

.088

.263

1

.608

2.969

1

.085

Exact Sig.
(2-sided-)

.286

Fisher's Exact Test
Linear-by-Linear
Association

2.500

N of Valid Cases

7

1

Exact Sig.
(1-sided)

.286

.114
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Finding 4 - 92.8 percent confident
Variable I: Cardiology Imaging Purchase Plans
Variable 2: Purchase Intention
We are 92.8 percent confident that this is a significant association that should be further
investigated to see if a time ordered relationship and correlation exist between these variables.
Cardiology Imaging Purchase Plans· Purchase Intention Cross Tabulation
Purchase Intention
Very
Uninterested
Cardiology Imaging
Purchase Plans

Uninterested

Total

Interested

Very
Interested

No

1

0

1

0

Yes

0

4

0

1

5

1

4

1

1

7

Total

2

Chi-Square Tests

Pearson Chi-Square
Likelihood Ratio
Linear-by-Linear
Association
N of Valid Cases

Asymp. Sig.
(2-sided)

df

Value
7.000(a)
8.376

3
3

.072
.039

.007

1

.932

7
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Finding 5 - 91.8 percent confident
Variable I: Cardiology Imaging Installation Time
Variable 2: Women's Health Installation Time
We are 91.8 percent confident that these findings are representati ve of the population.
Cardiology Imaging Installation Date * Women's Health Installation Date Cross Tabulation
Women's Health Installation Date
Unknown
Cardiology Imaging
Installation Date

2007
2008

Total

2007

Total

2008

0

2

1

0

2

3

1

2

2

5

0

2

Chi-Square Tests

Value
Pearson Chi-Square
Likelihood Ratio
Linear-by-Linear
Association
N of Valid Cases

Asymp. Sig.
(2-sidedl'

df

5.000(a)
6.730

2
2

.082
.035

.190

1

.663

5
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Finding 6 - 95.4 percent confident
Variable J: Women's Health Purchase Plans
Variable 2: Nuclear Medicine Equipment - Upgrade/New Installation
We are 95.4 percent confident that the association between these two variables is significant.
Women's Health Purchase Plans * Nuclear Medicine Equipment - Upgrade/New Installation Cross Tabulation
Nuclear Medicine
Egui )ment
Upgrade
No

Women's Health
Purchase Plans

1

Yes
Total

Total

New Install
0

1

0

3

3

1

3

4

Chi-Square Tests

Value
Pearson Chi-Square
Continuity
Correction(a)
Likelihood Ratio

Asymp. Sig.
(2-sidedl-

Df

4.000(b)

1

.046

.444

1

.505

4.499

1

.034

Fisher's Exact Test

Exact Sig.
12-sided)

.250

Linear-by-Linear
Association

3.000

N of Valid Cases

4

1

Exact Sig.
(1-sided-)

.250

.083
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Finding 7 - 92.4 percent confident
Variable I: Women's Health Purchase Plans
Variable 2: DRA Effects
We are 92.4 percent confident that these findings are representative of the population.
Women's Health Purchase Plans * ORA Effects Cross Tabulation

DRA Effects
Lower Reimbursements/
Revenues

No
Purchases

1

5

2

8

5

3

0

8

6

8

2

16

No Effect
Women's Health
Purchase Plans

No
Yes

Total

Total

Chi-Square Tests

Value
Pearson Chi-Square
Likelihood Ratio
Linear-by-Linear
Association
N of Valid Cases

Asymp. Sig.
(2-sidedl

df

5.167(a)
6.189

2
2

.076
.045

4.821

1

.028

16
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APPENDIX D: PURCHASE INTENTION
Question: How interested would you be in an independent report containing side-by-side vendor
performance comparisons for each modality?

I

6.67%

4

26.67%

Undecided

I

6.67%

Uninterested

7

46.67%

Very Uninterested

2

13.33%

Total

15

100%

0%
100%

-

2

o

15

2.05
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